CEO of Dotmatics Discusses Artificial Intelligence for Medical Research
Thomas Swalla, CEO of Dotmatics, discusses on Good Morning Chicago how artificial intelligence is transforming medical research by improving medical decisions and treatments, while Dotmatics leverages AI to reduce drug discovery costs.
Thomas Swalla joins Good Morning Chicago to discuss trends in how artificial intelligence is impacting medical decisions and treatments on a broad scale.
Learn More About Dotmatics
Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.